• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

孤立性髓过氧化物酶-抗中性粒细胞胞质抗体相关性肥厚性硬脑膜炎。

Isolated Myeloperoxidase-Antineutrophil Cytoplasmic Antibody-Associated Hypertrophic Pachymeningitis.

机构信息

From the Departments of Neurology.

Pathology.

出版信息

J Clin Rheumatol. 2022 Apr 1;28(3):e672-e674. doi: 10.1097/RHU.0000000000001845.

DOI:10.1097/RHU.0000000000001845
PMID:35325906
Abstract

A 65-year-old man with no pertinent medical history presented with 1 month of progressive holocephalic positional headaches (worse supine), photophobia, progressive gait instability resulting in multiple falls (ambulatory to walker in only 2 months), and weight loss. Testing found positive ANCA 1:160 perinuclear patter, myeloperoxidase >8.0. Cerebrospinal fluid found lymphocytic pleocytosis. We present his neuroimaging of isolated hypertrophic pachymeningitis with clinicoradiographic resolution after immunomodulatory pharmacotherapy along with histology from his meningeal biopsy. Isolated vasculitic myeloperoxidase-antineutrophil cytoplasmic antibody hypertrophic pachymeningitis is quite rare.

摘要

一位 65 岁的男性,无相关病史,表现为 1 个月进行性全颅位头痛(仰卧位时更严重)、畏光、进行性步态不稳导致多次跌倒(仅 2 个月内从能行走进展至需使用助行器)和体重减轻。检查发现抗中性粒细胞胞浆抗体 1:160 核周型阳性,髓过氧化物酶>8.0。脑脊液检查发现淋巴细胞增多。我们报告了他孤立性肥厚性硬脑膜炎的神经影像学表现,经免疫调节药物治疗后临床和影像学均缓解,同时也报告了脑膜活检的组织学结果。孤立性血管炎、髓过氧化物酶-抗中性粒细胞胞浆抗体阳性、肥厚性硬脑膜炎非常罕见。

相似文献

1
Isolated Myeloperoxidase-Antineutrophil Cytoplasmic Antibody-Associated Hypertrophic Pachymeningitis.孤立性髓过氧化物酶-抗中性粒细胞胞质抗体相关性肥厚性硬脑膜炎。
J Clin Rheumatol. 2022 Apr 1;28(3):e672-e674. doi: 10.1097/RHU.0000000000001845.
2
Hypertrophic pachymeningitis: significance of myeloperoxidase anti-neutrophil cytoplasmic antibody.肥厚性硬脑膜炎:髓过氧化物酶抗中性粒细胞胞质抗体的意义。
Brain. 2014 Feb;137(Pt 2):520-36. doi: 10.1093/brain/awt314. Epub 2013 Nov 22.
3
Hypertrophic Pachymeningitis Associated with Myeloperoxidase-anti-neutrophil Cytoplasmic Antibodies Induced by Propylthiouracil.丙硫氧嘧啶诱导的髓过氧化物酶-抗中性粒细胞胞质抗体相关性肥厚性硬脑膜炎。
Intern Med. 2023 Jul 1;62(13):1951-1955. doi: 10.2169/internalmedicine.0692-22. Epub 2022 Nov 16.
4
Optic neuropathy secondary to granulomatosis with polyangiitis in a patient with Graves' disease: a case report.继发于 Graves 病患者的肉芽肿性多血管炎的视神经病变:一例报告。
J Med Case Rep. 2021 Dec 29;15(1):618. doi: 10.1186/s13256-021-03207-4.
5
[Clinical analysis of 15 cases with myeloperoxidase antineutrophil cytoplasmic antibody associated hypertrophic pachymeningitis].髓过氧化物酶抗中性粒细胞胞浆抗体相关肥厚性硬脑膜炎15例临床分析
Zhonghua Nei Ke Za Zhi. 2022 May 1;61(5):565-569. doi: 10.3760/cma.j.cn112138-20210701-00455.
6
Pachymeningitis associated with IgG4-related disease and ANCA positivity: Case report and review of the literature.与IgG4相关疾病及抗中性粒细胞胞浆抗体阳性相关的硬脑膜炎:病例报告及文献复习
Autoimmun Rev. 2023 Apr;22(4):103285. doi: 10.1016/j.autrev.2023.103285. Epub 2023 Feb 2.
7
[Clinical analyses of perinuclear antineutrophil cytoplasmic antibody associated hypertrophic pachymeningitis].核周型抗中性粒细胞胞浆抗体相关性肥厚性硬脑膜炎的临床分析
Zhonghua Yi Xue Za Zhi. 2013 Mar 19;93(11):837-40.
8
Hypertrophic pachymeningitis with MPO-ANCA-positive vasculitis.伴有 MPO-ANCA 阳性血管炎的肥厚性硬脑膜炎。
Clin Rheumatol. 2010 Jan;29(1):111-3. doi: 10.1007/s10067-009-1269-x. Epub 2009 Sep 2.
9
The Successful Treatment of Myeloperoxidase Antineutrophil Cytoplasmic Antibody-positive Hypertrophic Pachymeningitis in Patients with the Limited Form of Granulomatosis with Polyangiitis Using Methotrexate: Two Case Reports.甲氨蝶呤成功治疗局限型肉芽肿性多血管炎患者的髓过氧化物酶抗中性粒细胞胞浆抗体阳性肥厚性硬脑膜炎:两例报告
Intern Med. 2017;56(8):959-965. doi: 10.2169/internalmedicine.56.7742. Epub 2017 Apr 15.
10
Hypertrophic pachymeningitis and cerebral venous thrombosis in myeloperoxidase-ANCA associated vasculitis.髓过氧化物酶抗中性粒细胞胞浆抗体相关性血管炎中的肥厚性硬脑膜炎和脑静脉血栓形成
BMJ Case Rep. 2019 Jan 10;12(1):bcr-2018-226780. doi: 10.1136/bcr-2018-226780.